Polymeric drugs: Advances in the development of pharmacologically active polymers.

Synthetic polymers play a critical role in pharmaceutical discovery and development. Current research and applications of pharmaceutical polymers are mainly focused on their functions as excipients and inert carriers of other pharmacologically active agents. This review article surveys recent advances in alternative pharmaceutical use of polymers as pharmacologically active agents known as polymeric drugs. Emphasis is placed on the benefits of polymeric drugs that are associated with their macromolecular character and their ability to explore biologically relevant multivalency processes. We discuss the main therapeutic uses of polymeric drugs as sequestrants, antimicrobials, antivirals, and anticancer and anti-inflammatory agents.

[1]  N. Rivard,et al.  Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. , 2009, Gastroenterology.

[2]  W. DeGrado,et al.  The role of hydrophobicity in the antimicrobial and hemolytic activities of polymethacrylate derivatives. , 2009, Chemistry.

[3]  B. Sullenger,et al.  Nucleic acid-binding polymers as anti-inflammatory agents: reducing the danger of nuclear attack , 2012, Expert review of clinical immunology.

[4]  A. Caminade,et al.  A Phosphorus-Based Dendrimer Targets Inflammation and Osteoclastogenesis in Experimental Arthritis , 2011, Science Translational Medicine.

[5]  H. Schneider.  Supramolecular Systems in Biomedical Fields , 2013 .

[6]  M. Hirsch,et al.  Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities , 1996, Antimicrobial agents and chemotherapy.

[7]  A. Schätzlein,et al.  Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. , 2005, Cancer research.

[8]  C. Labranche,et al.  Evaluation of the synthesis of sialic acid-PAMAM glycodendrimers without the use of sugar protecting groups, and the anti-HIV-1 properties of these compounds. , 2011, Bioconjugate chemistry.

[9]  R. Romero,et al.  Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers. , 2010, International journal of pharmaceutics.

[10]  A. Imberty,et al.  Glycomimetics and glycodendrimers as high affinity microbial anti-adhesins. , 2008, Chemistry.

[11]  Mark M. Banaszak Holl,et al.  Multivalent Polymers for Drug Delivery and Imaging: The Challenges of Conjugation , 2014, Biomacromolecules.

[12]  Xiaole Kong,et al.  Iron binding dendrimers: a novel approach for the treatment of haemochromatosis. , 2006, Journal of medicinal chemistry.

[13]  Mark E. Davis,et al.  Development of universal antidotes to control aptamer activity , 2009, Nature Medicine.

[14]  G. O’Toole,et al.  Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases. , 2012, Molecular pharmaceutics.

[15]  Ming Zhao,et al.  Synthesis and in vivo lead detoxification evaluation of Poly-α,β-dl-aspartyl-l-methionine. , 2012, Chemical research in toxicology.

[16]  F. Krebs,et al.  A Styrene-alt-Maleic Acid Copolymer Is an Effective Inhibitor of R5 and X4 Human Immunodeficiency Virus Type 1 Infection , 2010, Journal of biomedicine & biotechnology.

[17]  G. Edan,et al.  Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response , 2010, Journal of Neuroimmunology.

[18]  M. Tonelli,et al.  Oral phosphate binders in patients with kidney failure. , 2010, The New England journal of medicine.

[19]  H. Burt,et al.  In vitro chelating, cytotoxicity, and blood compatibility of degradable poly(ethylene glycol)-based macromolecular iron chelators. , 2009, Biomaterials.

[20]  G. Tack,et al.  The spectrum of celiac disease: epidemiology, clinical aspects and treatment , 2010, Nature Reviews Gastroenterology &Hepatology.

[21]  S. Falk,et al.  Nylon-3 polymers active against drug-resistant Candida albicans biofilms. , 2015, Journal of the American Chemical Society.

[22]  G. Armstrong,et al.  Impact of the Nature and Size of the Polymeric Backbone on the Ability of Heterobifunctional Ligands to Mediate Shiga Toxin and Serum Amyloid P Component Ternary Complex Formation , 2011, Toxins.

[23]  D. Oupický,et al.  Examination of Structure–Activity Relationship of Viologen-Based Dendrimers as CXCR4 Antagonists and Gene Carriers , 2014, Bioconjugate chemistry.

[24]  T. Vorup-Jensen.  On the roles of polyvalent binding in immune recognition: perspectives in the nanoscience of immunology and the immune response to nanomedicines. , 2012, Advanced drug delivery reviews.

[25]  Wenchen Zhao,et al.  Targeted Delivery of Doxorubicin by Folic Acid-Decorated Dual Functional Nanocarrier , 2014, Molecular pharmaceutics.

[26]  B. Richardson,et al.  Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004) , 2011, AIDS.

[27]  B. Sullenger,et al.  The Nucleic Acid Scavenger Polyamidoamine Third-Generation Dendrimer Inhibits Fibroblast Activation and Granulation Tissue Contraction , 2014, Plastic and reconstructive surgery.

[28]  D. Breslow.  Biologically Active Synthetic Polymers , 1976 .

[29]  Sean P. Palecek,et al.  Structure–Activity Relationships among Antifungal Nylon-3 Polymers: Identification of Materials Active against Drug-Resistant Strains of Candida albicans , 2014, Journal of the American Chemical Society.

[30]  Y. Yeo,et al.  Drug Carriers: Not an Innocent Delivery Man , 2015, The AAPS Journal.

[31]  Hao Liu,et al.  An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[32]  J. Aronson.  Safety , 2009, BMJ : British Medical Journal.

[33]  R. Haag,et al.  Inhibition of Influenza Virus Activity by Multivalent Glycoarchitectures with Matched Sizes , 2011, Chembiochem : a European journal of chemical biology.

[34]  P. Marcato,et al.  Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands. , 2003, The Journal of infectious diseases.

[35]  Sheena McCormack,et al.  PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial , 2010, The Lancet.

[36]  Maarten Danial,et al.  Polymeric anti-HIV therapeutics. , 2015, Macromolecular bioscience.

[37]  P. Gorry,et al.  Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1. , 2011, Antiviral research.

[38]  D. Oupický,et al.  Dual-function CXCR4 antagonist polyplexes to deliver gene therapy and inhibit cancer cell invasion. , 2012, Angewandte Chemie.

[39]  K. Kuroda,et al.  Cationic Methacrylate Polymers as Topical Antimicrobial Agents against Staphylococcus aureus Nasal Colonization , 2014, Biomacromolecules.

[40]  S. Nazzal,et al.  Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[41]  S. Cooper,et al.  Interactions between dendrimer biocides and bacterial membranes. , 2002, Biomaterials.

[42]  E. De Clercq,et al.  Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle. , 2000, Molecular pharmacology.

[43]  George M. Whitesides,et al.  Designing a polyvalent inhibitor of anthrax toxin , 2001, Nature Biotechnology.

[44]  M. Akashi,et al.  A strontium-90 sequestrant for first-aid treatment of radiation emergency. , 2012, Chemical & pharmaceutical bulletin.

[45]  E. De Clercq,et al.  "Viologen" dendrimers as antiviral agents: the effect of charge number and distance. , 2010, Journal of medicinal chemistry.

[46]  D. Keskin,et al.  Amelioration of proteolipid protein 139-151-induced encephalomyelitis in SJL mice by modified amino acid copolymers and their mechanisms. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  S. Gellman,et al.  Effects of Cyclic vs. Acyclic Hydrophobic Subunits on the Chemical Structure and Biological Properties of Nylon-3 Co-Polymers. , 2013, ACS macro letters.

[48]  Lin Mei,et al.  Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. , 2014, Biomaterials.

[49]  R. Haag,et al.  Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation , 2010, Proceedings of the National Academy of Sciences.

[50]  Yung-wu Chen,et al.  VS-501: a novel, nonabsorbed, calcium- and aluminum-free, highly effective phosphate binder derived from natural plant polymer , 2014, Pharmacology research & perspectives.

[51]  R. Burrier,et al.  Toxin binding of tolevamer, a polyanionic drug that protects against antibiotic-associated diarrhea. , 2004, Biophysical journal.

[52]  T. Spelman,et al.  SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans , 2011, PloS one.

[53]  J. Kopeček,et al.  HPMA Copolymer CXCR4 Antagonist Conjugates Substantially Inhibited the Migration of Prostate Cancer Cells , 2014, ACS macro letters.

[54]  D. Brooks,et al.  The influence of poly-N-[(2,2-dimethyl-1,3-dioxolane)methyl]acrylamide on fibrin polymerization, cross-linking and clot structure. , 2010, Biomaterials.

[55]  Robert J. Miller,et al.  Functional polymers as therapeutic agents: concept to market place. , 2009, Advanced drug delivery reviews.

[56]  R. Kane,et al.  The design of polyvalent therapeutics. , 2008, Chemistry.

[57]  Hans-Jörg Schneider,et al.  Binding mechanisms in supramolecular complexes. , 2009, Angewandte Chemie.

[58]  J S Wolinsky,et al.  Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability , 1998, Neurology.

[59]  P. Koenig,et al.  Amino Acid Copolymers That Alleviate Experimental Autoimmune Encephalomyelitis In Vivo Interact with Heparan Sulfates and Glycoprotein 96 in APCs , 2013, The Journal of Immunology.

[60]  W. DeGrado,et al.  Amphiphilic polymethacrylate derivatives as antimicrobial agents. , 2005, Journal of the American Chemical Society.

[61]  A. Schmidtchen,et al.  Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymer. , 2004, Journal of Antimicrobial Chemotherapy.

[62]  R. Read,et al.  Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands , 2000, Nature.

[63]  N. Amin.  The impact of improved phosphorus control: use of sevelamer hydrochloride in patients with chronic renal failure. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[64]  J. Leroux,et al.  New pharmaceutical applications for macromolecular binders. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[65]  Takami Kanno,et al.  Pulmonary , gastrointestinal and urogenital pharmacology Effect of fatty acids on the phosphate binding of TRK-390 , a novel , highly selective phosphate-binding polymer , 2013 .

[66]  H. Griesser,et al.  Guanylated polymethacrylates: a class of potent antimicrobial polymers with low hemolytic activity. , 2013, Biomacromolecules.

[67]  T. Neenan,et al.  Hydroxamic acid-containing hydrogels for nonabsorbed iron chelation therapy: synthesis, characterization, and biological evaluation. , 2005, Biomacromolecules.

[68]  J. Kopeček,et al.  Drug-free macromolecular therapeutics: induction of apoptosis by coiled-coil-mediated cross-linking of antigens on the cell surface. , 2010, Angewandte Chemie.

[69]  C. Wanner,et al.  The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[70]  J. Kopeček,et al.  Cell surface self-assembly of hybrid nanoconjugates via oligonucleotide hybridization induces apoptosis. , 2014, ACS nano.

[71]  G. Tew,et al.  Nonhemolytic abiogenic polymers as antimicrobial peptide mimics , 2004 .

[72]  J. Murray,et al.  The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues. , 2012, Gastroenterology.

[73]  Paul M. Levine,et al.  Crafting precise multivalent architectures , 2013 .

[74]  W. Insull.  Clinical Utility of Bile Acid Sequestrants in the Treatment of Dyslipidemia: A Scientific Review , 2006, Southern medical journal.

[75]  A. Patat,et al.  Safety, Pharmacokinetic, and Pharmacodynamic Evaluations of PI‐2301, a Potent Immunomodulator, in a First‐in‐Human, Single‐Ascending‐Dose Study in Healthy Volunteers , 2011, Journal of clinical pharmacology.

[76]  Suzie H. Pun,et al.  A synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis , 2015, Science Translational Medicine.

[77]  B. Sullenger,et al.  Nucleic acid-binding polymers as anti-inflammatory agents , 2011, Proceedings of the National Academy of Sciences.

[78]  K. Weiss.  Toxin-binding treatment for Clostridium difficile: a review including reports of studies with tolevamer. , 2009, International journal of antimicrobial agents.

[79]  D. Eiler,et al.  Spacer-based selectivity in the binding of "two-prong" ligands to recombinant human carbonic anhydrase I. , 2005, Biochemistry.

[80]  Xiaole Kong,et al.  Synthesis and iron(III)-chelating properties of novel 3-hydroxypyridin-4-one hexadentate ligand-containing copolymers. , 2008, Biomacromolecules.

[81]  D. Oupický,et al.  Development of Functional Poly(amido amine) CXCR4 Antagonists with the Ability to Mobilize Leukocytes and Deliver Nucleic Acids , 2015, Advanced healthcare materials.

[82]  H. Gendelman,et al.  Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[83]  Y. Chen,et al.  Balancing polymer hydrophobicity for ligand presentation and siRNA delivery in dual function CXCR4 inhibiting polyplexes. , 2015, Biomaterials science.

[84]  H. Klenk,et al.  Polymer-bound 6' sialyl-N-acetyllactosamine protects mice infected by influenza virus. , 2005, Antiviral research.

[85]  Yaping Li,et al.  Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer. , 2012, Biomaterials.

[86]  Ruth Duncan,et al.  Polymer therapeutics: Top 10 selling pharmaceuticals - what next? , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[87]  L. Kiessling,et al.  Synthetic multivalent ligands in the exploration of cell-surface interactions. , 2000, Current opinion in chemical biology.

[88]  S. Simões,et al.  Polymeric bile acid sequestrants—Synthesis using conventional methods and new approaches based on “controlled”/living radical polymerization , 2013 .

[89]  Amanda C. Engler,et al.  Antimicrobial polycarbonates: investigating the impact of balancing charge and hydrophobicity using a same-centered polymer approach. , 2013, Biomacromolecules.

[90]  V. Préat,et al.  Vitamin E-based nanomedicines for anti-cancer drug delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[91]  M. Subirade,et al.  Interaction of alpha-gliadin with polyanions: design considerations for sequestrants used in supportive treatment of celiac disease. , 2010, Biopolymers.

[92]  M. Zasloff.  Antimicrobial peptides of multicellular organisms , 2002, Nature.

[93]  Massimo Filippi,et al.  European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity and burden in patients with relapsing multiple sclerosis , 2001, Annals of neurology.

[94]  M. Yamashita,et al.  Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives. , 2002, Bioorganic & medicinal chemistry letters.

[95]  B. Sullenger,et al.  RNA aptamers as reversible antagonists of coagulation factor IXa , 2002, Nature.

[96]  Dendrimers as bactericides , 2012 .

[97]  G M Whitesides,et al.  Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition. , 1995, Journal of medicinal chemistry.

[98]  F. Krebs,et al.  Novel Polysulfated Galactose-Derivatized Dendrimers as Binding Antagonists of Human Immunodeficiency Virus Type 1 Infection , 2004, Antimicrobial Agents and Chemotherapy.

[99]  Alexander V Kabanov,et al.  Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[100]  Kristi L Kiick,et al.  Polymer-Based Therapeutics. , 2009, Macromolecules.

[101]  M. Klein,et al.  Characterization of nonbiological antimicrobial polymers in aqueous solution and at water-lipid interfaces from all-atom molecular dynamics. , 2006, Journal of the American Chemical Society.

[102]  V. Venditto,et al.  Synthesis and characterization of a triazine dendrimer that sequesters iron(III) using 12 desferrioxamine B groups. , 2010, Bioorganic & medicinal chemistry.

[103]  L. Seymour,et al.  Review : Synthetic Polymers with Intrinsic Anticancer Activity , 1991 .

[104]  Norihiro Suzuki,et al.  Current Concepts in Multiple Sclerosis: Autoimmunity Versus Oligodendrogliopathy , 2012, Clinical Reviews in Allergy & Immunology.

[105]  K. Abbott,et al.  Damned if you do, damned if you don't: potassium binding resins in hyperkalemia. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[106]  D. Schols,et al.  HIV-1 X4 activities of polycationic "viologen" based dendrimers by interaction with the chemokine receptor CXCR4: study of structure-activity relationship. , 2012, Journal of medicinal chemistry.

[107]  G. Armstrong,et al.  In vivo supramolecular templating enhances the activity of multivalent ligands: A potential therapeutic against the Escherichia coli O157 AB5 toxins , 2008, Proceedings of the National Academy of Sciences.

[108]  M. Vicent,et al.  Polymer therapeutics-prospects for 21st century: the end of the beginning. , 2013, Advanced drug delivery reviews.

[109]  S. Gellman,et al.  Structure-activity relationships among random nylon-3 copolymers that mimic antibacterial host-defense peptides. , 2009, Journal of the American Chemical Society.

[110]  Hiroyuki Koide,et al.  The rational design of a synthetic polymer nanoparticle that neutralizes a toxic peptide in vivo , 2011, Proceedings of the National Academy of Sciences.

[111]  J. Silverman,et al.  Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS) , 1999, Pharmaceutical Research.

[112]  J. Kopeček,et al.  Anti-CD20 multivalent HPMA copolymer-Fab' conjugates for the direct induction of apoptosis. , 2012, Biomaterials.

[113]  Hiroyuki Koide,et al.  Recognition, neutralization, and clearance of target peptides in the bloodstream of living mice by molecularly imprinted polymer nanoparticles: a plastic antibody. , 2010, Journal of the American Chemical Society.

[114]  A. Munson,et al.  A comparative study of antitumour and toxicologic properties of related polyanions , 1977 .

[115]  A. Kabanov,et al.  Pluronics and MDR Reversal: An Update , 2014, Molecular pharmaceutics.

[116]  F. Liu,et al.  Combinational Delivery of Hydrophobic and Hydrophilic Anticancer Drugs in Single Nanoemulsions To Treat MDR in Cancer , 2014, Molecular pharmaceutics.

[117]  S. Gellman,et al.  Tuning the Biological Activity Profile of Antibacterial Polymers via Subunit Substitution Pattern , 2014, Journal of the American Chemical Society.

[118]  S. Gellman,et al.  Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides. , 2008, Journal of molecular biology.

[119]  A. Caminade,et al.  Multiplication of human natural killer cells by nanosized phosphonate-capped dendrimers. , 2007, Angewandte Chemie.

[120]  George Quick,et al.  Antidote-mediated control of an anticoagulant aptamer in vivo , 2004, Nature Biotechnology.

[121]  Bing‐Huei Chen,et al.  In vitro adsorption of aluminum by an edible biopolymer poly(γ-glutamic acid). , 2014, Journal of agricultural and food chemistry.

[122]  A. Rubio‐Tapia,et al.  ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease , 2013, The American Journal of Gastroenterology.

[123]  Cameron Alexander,et al.  Bacteria-instructed synthesis of polymers for self-selective microbial binding and labelling , 2014, Nature materials.

[124]  Jason E Gestwicki,et al.  Synthetic multivalent ligands as probes of signal transduction. , 2006, Angewandte Chemie.

[125]  R. Grubbs,et al.  Inhibition of cell adhesion to fibronectin by oligopeptide-substituted polynorbornenes. , 2001, Journal of the American Chemical Society.

[126]  G. Whitesides,et al.  Generation and in Situ Evaluation of Libraries of Poly(acrylic acid) Presenting Sialosides as Side Chains as Polyvalent Inhibitors of Influenza-Mediated Hemagglutination , 1997 .

[127]  David R. Liu,et al.  Sequence-Controlled Polymers , 2013, Science.

[128]  D. Santoro,et al.  Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients. , 2009, Journal of the American Society of Nephrology : JASN.

[129]  K. Kuroda,et al.  Poly(ethylene imine)s as antimicrobial agents with selective activity. , 2012, Macromolecular bioscience.

[130]  B. Sullenger,et al.  The Inhibition of Anti-DNA Binding to DNA by Nucleic Acid Binding Polymers , 2012, PloS one.

[131]  J. Strominger,et al.  T cell receptors in an IL-10-secreting amino acid copolymer-specific regulatory T cell line that mediates bystander immunosuppression , 2009, Proceedings of the National Academy of Sciences.

[132]  C. Brosnan,et al.  Modified amino acid copolymers suppress myelin basic protein 85-99-induced encephalomyelitis in humanized mice through different effects on T cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[133]  Liwei Hui,et al.  Long hydrophilic-and-cationic polymers: a different pathway toward preferential activity against bacterial over mammalian membranes. , 2014, Biomacromolecules.

[134]  G. Whitesides,et al.  Promotion of opsonization by antibodies and phagocytosis of Gram-positive bacteria by a bifunctional polyacrylamide. , 2006, Biomaterials.

[135]  GREGORY N. TEW,et al.  De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications. , 2010, Accounts of chemical research.

[136]  G. Tew,et al.  Tuning the hemolytic and antibacterial activities of amphiphilic polynorbornene derivatives. , 2004, Journal of the American Chemical Society.

[137]  B. Sullenger,et al.  Nucleic acid scavengers inhibit thrombosis without increasing bleeding , 2012, Proceedings of the National Academy of Sciences.

[138]  M. Elisaf,et al.  Hyperphosphatemia and phosphate binders: effectiveness and safety , 2014, Current medical research and opinion.

[139]  Ayusman Sen,et al.  Antibacterial and hemolytic activities of pyridinium polymers as a function of the spatial relationship between the positive charge and the pendant alkyl tail. , 2008, Angewandte Chemie.

[140]  C. Farina,et al.  Mechanisms of action of glatiramer acetate in multiple sclerosis , 2001, Neurology.

[141]  Christina Graf,et al.  Multivalency as a chemical organization and action principle. , 2012, Angewandte Chemie.

[142]  Zhou Wang,et al.  PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers. , 2013, Biomaterials.

[143]  D. Oupický,et al.  Polymeric Plerixafor: Effect of PEGylation on CXCR4 Antagonism, Cancer Cell Invasion, and DNA Transfection , 2014, Pharmaceutical Research.

[144]  J. Kizhakkedathu,et al.  Design of long circulating nontoxic dendritic polymers for the removal of iron in vivo. , 2013, ACS nano.

[145]  D. Bernstein,et al.  Evaluations of Unformulated and Formulated Dendrimer-Based Microbicide Candidates in Mouse and Guinea Pig Models of Genital Herpes , 2003, Antimicrobial Agents and Chemotherapy.

[146]  Xiaojun Feng,et al.  Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment. , 2015, Materials science & engineering. C, Materials for biological applications.

[147]  G. Whitesides,et al.  Polyacrylamides Bearing Pendant α-Sialoside Groups Strongly Inhibit Agglutination of Erythrocytes by Influenza Virus: The Strong Inhibition Reflects Enhanced Binding through Cooperative Polyvalent Interactions , 1996 .

[148]  S. Holmes-Farley,et al.  Effect of RenaGel, a non-absorbable, cross-linked, polymeric phosphate binder, on urinary phosphorus excretion in rats. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[149]  A. Bellasi,et al.  Phosphate binders: New products and challenges , 2006, Hemodialysis international. International Symposium on Home Hemodialysis.

[150]  S. Steinhubl,et al.  First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology: A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the Controlled Regulation of Factor IXa Activity , 2006, Circulation.

[151]  S. Falk,et al.  Nylon-3 polymers with selective antifungal activity. , 2013, Journal of the American Chemical Society.

[152]  F Fazekas,et al.  Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.

[153]  J. Wang,et al.  In vitro binding of heavy metals by an edible biopolymer poly(gamma-glutamic acid). , 2009, Journal of agricultural and food chemistry.

[154]  R. Kane,et al.  Synthesis of potent inhibitors of anthrax toxin based on poly-L-glutamic acid. , 2006, Bioconjugate chemistry.

[155]  J. Heuts,et al.  Effect of glycounits on the antimicrobial properties and toxicity behavior of polymers based on quaternized DMAEMA. , 2015, Biomacromolecules.

[156]  Xiangliang Yang,et al.  Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance. , 2014, Molecular pharmaceutics.

[157]  S. Wesselingh,et al.  Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral Activity , 2010, PloS one.

[158]  J. Kaldor,et al.  Safety, Tolerability, and Pharmacokinetics of SPL7013 Gel (VivaGel®): A Dose Ranging, Phase I Study , 2010, Sexually transmitted diseases.

[159]  C. Smulski,et al.  Multimerization of an apoptogenic TRAIL-mimicking peptide by using adamantane-based dendrons. , 2013, Chemistry.

[160]  George M Whitesides,et al.  Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.

[161]  O. Lenz,et al.  Phosphate control in end-stage renal disease: barriers and opportunities. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[162]  J. Kopeček,et al.  Coiled-coil based drug-free macromolecular therapeutics: in vivo efficacy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[163]  G. J. Gabriel,et al.  Comparison of facially amphiphilic versus segregated monomers in the design of antibacterial copolymers. , 2009, Chemistry.

[164]  Vipin Saxena,et al.  Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer , 2012, International journal of nanomedicine.

[165]  F. Liu,et al.  Paclitaxel nanocrystals for overcoming multidrug resistance in cancer. , 2010, Molecular pharmaceutics.

[166]  S. Gellman,et al.  Synthetic Polymers Active against Clostridium difficile Vegetative Cell Growth and Spore Outgrowth , 2014, Journal of the American Chemical Society.

[167]  J W Eaton,et al.  Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[168]  C. Wiegand,et al.  Poly(ethyleneimines) in dermal applications: biocompatibility and antimicrobial effects. , 2013, International journal of pharmaceutics.

[169]  A. Benesi,et al.  Synthesis of novel, multivalent glycodendrimers as ligands for HIV-1 gp120. , 2004, Bioconjugate chemistry.

[170]  W. Turnbull,et al.  Bacterial toxin inhibitors based on multivalent scaffolds. , 2013, Chemical Society reviews.

[171]  David Miles,et al.  Combination versus sequential single-agent therapy in metastatic breast cancer. , 2002, The oncologist.

[172]  G. Tew,et al.  Antimicrobial polymers prepared by ROMP with unprecedented selectivity: a molecular construction kit approach. , 2008, Journal of the American Chemical Society.

[173]  J. Murray,et al.  BL-7010 Demonstrates Specific Binding to Gliadin and Reduces Gluten-Associated Pathology in a Chronic Mouse Model of Gliadin Sensitivity , 2014, PloS one.

[174]  R. Hider,et al.  Design of clinically useful macromolecular iron chelators , 2011, The Journal of pharmacy and pharmacology.

[175]  D. Oupický,et al.  Effect of biodegradability on CXCR4 antagonism, transfection efficacy and antimetastatic activity of polymeric Plerixafor. , 2014, Biomaterials.

[176]  W. Suki,et al.  Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. , 2007, Kidney international.

[177]  P. Ferruti.  Poly(amidoamine)s: Past, present, and perspectives , 2013 .

[178]  Zhiping Zhang,et al.  The applications of Vitamin E TPGS in drug delivery. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[179]  S. Gellman,et al.  Mimicry of antimicrobial host-defense peptides by random copolymers. , 2007, Journal of the American Chemical Society.

[180]  R. Kane,et al.  Synthesis of Homopolymers and Copolymers Containing an Active Ester of Acrylic Acid by RAFT: Scaffolds for Controlling Polyvalent Ligand Display. , 2008, Journal of polymer science. Part A, Polymer chemistry.

[181]  R. Duncan.  The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.